U.S. stock night market opening fluctuations: Silvaco fell 7.75% in night trading; Yunji fell 7.18% in night trading

U.S. Stock Night Market Opening Movements Silvaco fell 7.75% in the night market. Based on recent key news: On March 13, Silvaco's annual report showed that although revenue grew by 6% to $63.1 million, net losses widened to $41.2 million due to increased R&D and litigation costs. This financial performance raised market concerns, leading to a decline in stock price. Source: SEC announcement On March 13, Silvaco's fourth-quarter conference call emphasized the strong performance of AI-driven TCAD and IP growth, with management expecting double-digit revenue growth and further cost reductions by 2026. However, concerns about profitability remain, affecting the stock price. Source: Company conference call On March 14, analysts maintained a buy rating on Silvaco, but TipRanks' OpenAI reiterated a hold rating, reflecting market uncertainty about the company's future profitability. Source: Rosenblatt Securities and TipRanks analyst reports highlight cost pressures and growth challenges in the tech industry. Yunji fell 7.18% in the night market, with no significant news recently. Trading was active, and capital flow was evident. Considering sector and industry trends, the stock showed significant volatility, with specific reasons needing further observation. Top Gainers in the U.S. Stock Night Market Dragonfly Energy rose 17.73% in the night market, with no significant news recently. Trading was active, and capital flow was evident. Considering sector and industry trends, the stock showed significant volatility, with specific reasons needing further observation. Aldeyra Therapeutics rose 16.36% in the night market. Based on recent news: On March 13, Aldeyra Therapeutics' stock options trading was active, indicating strong market interest in the stock. According to data from StockOptionsChannel.com, the options trading volume for Aldeyra Therapeutics significantly increased, reflecting investors' optimistic expectations for its future performance. On March 13, Aldeyra Therapeutics announced that its brand influence in the North American health and wellness market continues to expand. LifeBridge announced that its brand is launching in Central California, further enhancing Aldeyra Therapeutics' visibility and market share in the region. On March 13, Aldeyra Therapeutics' stock was active in the S&P 500 index, becoming one of the most active call and put options of the day. This indicates that investors are confident about the stock's future trends, driving its price up. Increased market interest in the health and wellness industry has propelled related stocks upward. Bath & Body Works rose 12.82% in the night market. Based on recent key news: On March 12, Bath & Body Works released an important announcement through the EDGAR system, which may involve financial or strategic adjustments of the company, driving the stock price up. The announcement was disclosed on the company's official website, but specific details were not provided. On March 12, Marcus & Millichap arranged the sale of McHenry Town Center, which includes a shopping center with Bath & Body Works as a tenant, with a transaction amount of $13.74 million. This transaction may have increased market attention on Bath & Body Works, indirectly affecting the stock price. There are no other significant news recently. The U.S. retail industry has shown strong performance recently, with noticeable capital inflows